An autologous point-of-care cell therapy for adults with ischemic HF with reduced ejection fraction was safe and may be beneficial for select candidates, though a pivotal study did not meet its ...

Tenax Therapeutics progresses levosimendan for PH-HFpEF with Phase 3 trials, aiming for a first-of-its-kind therapy. Click ...

Use of routine thoracentesis in addition to medical therapy yielded no significant benefits for adults with heart failure and ...

Finerenone prevented new-onset atrial fibrillation or flutter in patients with chronic kidney disease and type 2 diabetes or ...

Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.

Heart failure is linked with a decline in cognition when it is diagnosed, according to new data. Researchers evaluated the cognitive abilities of 29,614 adults over a median of 6.6 years ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, ...

Kidney Disease and Heart Failure The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) ...

Market failure refers to a situation defined by an inefficient distribution of goods and services in the free market. In an ideally functioning market, the forces of supply and demand balance each ...

At one year, patients taking tirzepatide had a 38% lower rate of cardiovascular death or worsening heart failure (defined as worsening heart failure symptoms in addition to hospitalization or the ...

25) explored the effects of finerenone (Kerendia; Bayer HealthCare) on clinical outcomes and bilirubin levels in patients with heart failure with preserved ejection fraction. Although recent ...

SUMMIT was the first trial in patients with heart failure with preserved ejection fraction (HFpEF ... like peptide-1 receptor agonist (GLP-1RA) tirzepatide, which is marketed as Mounjaro, on ...